Citation Impact
Citing Papers
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
Development and validation of the Nancy histological index for UC
2015 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
2005 Standout
Reactive Oxygen Species and the Central Nervous System
1992 Standout
Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
1994 Standout
Pleiotropic Roles of Bile Acids in Metabolism
2013
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Gut microbiota functions: metabolism of nutrients and other food components
2017 Standout
Bowel Disorders
2016 Standout
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
2004 Standout
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures
2010
Microemulsion-based media as novel drug delivery systems
2000 Standout
Guidelines for the management of inflammatory bowel disease in adults
2011
Long-Term Morbidity and Mortality of Overweight Adolescents
1992 Standout
A Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1 Represses Bile Acid Biosynthesis
2000 Standout
The effect of flavonoids on the reduction of cupric ions, the copper-driven Fenton reaction and copper-triggered haemolysis
2022
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Regulation of Complement C3 Expression by the Bile Acid Receptor FXR
2004
Effective removal of copper by plasma exchange in fulminant Wilson's disease
1998
Farnesoid X-Activated Receptor Induces Apolipoprotein C-II Transcription: a Molecular Mechanism Linking Plasma Triglyceride Levels to Bile Acids
2001
Irritable bowel syndrome
2016 Standout
Gut microbiome and health: mechanistic insights
2022 Standout
Ulcerative colitis
2012 Standout
Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Females With Functional Constipation
2011
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis
2010
Review article: remission rates achievable by current therapies for inflammatory bowel disease
2011
Therapeutic strategies for the management of ulcerative colitis
2008
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Bile salt biotransformations by human intestinal bacteria
2005 Standout
Drug-Induced Diarrhoea
2000
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Ulcerative colitis
2016 Standout
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
2004
Ulcerative colitis
2020 Standout
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
Energy Metabolism in the Liver
2014 Standout
Optimization of conventional therapy in patients with IBD
2011
The Asia‐Pacific consensus on ulcerative colitis
2010
Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials
2020
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
1995 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Management of Crohn's Disease in Adults
2009 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Antibiotic-Associated Diarrhea
2002 Standout
Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn’s disease—review of the literature
2010
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
The Farnesoid X Receptor
2005
Methotrexate for maintenance of remission in ulcerative colitis
2015
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
2003 StandoutNobel
Free radicals, antioxidants, and human disease: where are we now?
1992 Standout
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Obesity: adverse effects on health and longevity
1979
The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.
1978
[1] Role of free radicals and catalytic metal ions in human disease: An overview
1990 Standout
(C) Means to enhance penetration
1992
Quasielastic light-scattering studies of aqueous biliary lipid systems. Mixed micelle formation in bile salt-lecithin solutions
1980 Standout
The Yin and Yang of Oxidation in the Development of the Fatty Streak
1996 Standout
Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts
1986 Standout
LIPID PEROXIDATION AND THE CYTOTOXICITY OF COPPER*
1980
Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile
1995
Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR
2000
Nucleation time: A key factor in the pathogenesis of cholesterol gallstone disease
1979 Standout
Fatigue is highly associated with poor health‐related quality of life, disability and depression in newly‐diagnosed patients with inflammatory bowel disease, independent of disease activity
2014
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Oxygen toxicity, oxygen radicals, transition metals and disease
1984 Standout
Caeruloplasmin: Physiological and Pathological Perspectives
1981
Works of J. H. Iser being referenced
Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones
1978
Thiopurines, a previously unrecognised cause for fatigue in patients with inflammatory bowel disease
2009
Endoscopic balloon dilatation of intestinal strictures in Crohn's disease: Safe alternative to surgery
2006
A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: A case for subcutaneous administration
2007
Chenodeoxycholic Acid Treatment of Gallstones
1975
Chenodeoxycholic Acid
1981
Hemolytic Anemia of Wilson’s Disease
1974
Outcome of Chenodeoxycholic Acid (CDCA) Treatment in 125 Patients with Radiolucent Gallstones
1982